1. Home
  2. PHAR vs VREX Comparison

PHAR vs VREX Comparison

Compare PHAR & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • VREX
  • Stock Information
  • Founded
  • PHAR 1988
  • VREX 2016
  • Country
  • PHAR Netherlands
  • VREX United States
  • Employees
  • PHAR N/A
  • VREX N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • VREX Industrial Machinery/Components
  • Sector
  • PHAR Health Care
  • VREX Technology
  • Exchange
  • PHAR Nasdaq
  • VREX Nasdaq
  • Market Cap
  • PHAR 627.5M
  • VREX 582.3M
  • IPO Year
  • PHAR N/A
  • VREX N/A
  • Fundamental
  • Price
  • PHAR $9.98
  • VREX $13.52
  • Analyst Decision
  • PHAR Strong Buy
  • VREX Strong Buy
  • Analyst Count
  • PHAR 3
  • VREX 1
  • Target Price
  • PHAR $27.00
  • VREX $21.00
  • AVG Volume (30 Days)
  • PHAR 6.0K
  • VREX 475.8K
  • Earning Date
  • PHAR 03-13-2025
  • VREX 02-04-2025
  • Dividend Yield
  • PHAR N/A
  • VREX N/A
  • EPS Growth
  • PHAR N/A
  • VREX N/A
  • EPS
  • PHAR N/A
  • VREX N/A
  • Revenue
  • PHAR $285,745,000.00
  • VREX $811,000,000.00
  • Revenue This Year
  • PHAR $20.08
  • VREX $3.50
  • Revenue Next Year
  • PHAR $9.22
  • VREX $3.37
  • P/E Ratio
  • PHAR N/A
  • VREX N/A
  • Revenue Growth
  • PHAR 30.64
  • VREX N/A
  • 52 Week Low
  • PHAR $6.65
  • VREX $10.19
  • 52 Week High
  • PHAR $13.20
  • VREX $20.27
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 56.13
  • VREX 36.98
  • Support Level
  • PHAR $9.37
  • VREX $13.47
  • Resistance Level
  • PHAR $10.15
  • VREX $13.99
  • Average True Range (ATR)
  • PHAR 0.50
  • VREX 0.41
  • MACD
  • PHAR -0.09
  • VREX -0.08
  • Stochastic Oscillator
  • PHAR 57.53
  • VREX 18.69

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About VREX Varex Imaging Corporation

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital flat panel image detectors, high voltage connectors, ionization chambers, and buckys among others. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors and high voltage connectors among others. It has manufacturing, research, and development operation in the United States, Europe, Philippines and China, and sales and service operations throughout the world.

Share on Social Networks: